DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J. et al.
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: A randomized trial.
JAMA 2012;
307: 1265-72
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.